|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Rheumatoid Arthritis | |||||
| Healthy | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Arthritis | |||||
| Arthritis, Rheumatoid | |||||
| 3 | More general conditions related to this trial | ||||
| Autoimmune Diseases | |||||
| Connective Tissue Diseases | |||||
| Immune System Diseases | |||||
| Joint Diseases | |||||
| Musculoskeletal Diseases | |||||
| Rheumatic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Etanercept | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| TNFR-Fc fusion protein | |||||
| 6 | More general drug interventions related to this trial | ||||
| Analgesics | |||||
| Analgesics, Non-Narcotic | |||||
| Anti-Inflammatory Agents | |||||
| Anti-Inflammatory Agents, Non-Steroidal | |||||
| Antirheumatic Agents | |||||
| Central Nervous System Agents | |||||
| Gastrointestinal Agents | |||||
| Immunologic Factors | |||||
| Immunosuppressive Agents | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Sensory System Agents | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | |||||